NACDS gives take on proposed Medicaid reimbursement caps
The National Association of Chain Drug Stores has submitted comments to the Centers for Medicare & Medicaid Services (CMS) regarding its draft federal upper limit (FUL) list.
CDR
Report: In some categories, independents hold edge
Though the front end has traditionally been the province of chain drug stores, independent pharmacies are driving sales at a faster rate in six health-related categories, according to a new report from Hamacher Resource Group Inc.
Watson to market lower-dose testosterone patch
Watson Pharmaceuticals Inc. has received approval from the Food and Drug Administration for 2-mg and 4-mg formulations of its Androderm testosterone transdermal system.
Authorized generic pact signed by Prasco, Eli Lilly
Prasco Laboratories has entering a marketing and distribution agreement with Eli Lilly and Co. to market an authorized generic version of Zyprexa tablets and Zyprexa Zydis orally disintegrating tablets in the United States.
Senate nixes provision for ‘personal importation’ of Rx
The Senate has voted down a measure that would have enabled personal importation of prescription drugs into the United States.
Bayer category manager joins Emerson Group
The Emerson Group has hired Shane Brown to provide category management insight to its Walmart business team.
NCPA questions CMS calculations for FULs
The Centers for Medicare & Medicaid Services (CMS) is relying on flawed average manufacturer price (AMP) data to calculate new caps on Medicaid pharmacy reimbursement — known as federal upper limits (FULs) — for multiple-source generic prescription drugs, according to the National Community Pharmac
Abbott to split into two companies
Abbott has unveiled plans to separate into two publicly traded companies, one in diversified medical products and the other in research-based pharmaceuticals.
It’s official: Matrix renamed Mylan Laboratories
Mylan Inc. announced that its India-based subsidiary, Matrix Laboratories Ltd., has formally changed its name to Mylan Laboratories Ltd. The name change is effective immediately, the company said.
Senior management changes at Bristol-Myers Squibb
Bristol-Myers Squibb Co. has announced some executive moves within its senior management team. The company said Wednesday that Giovanni Caforio has been promoted to president of U.S. Pharmaceuticals. He previously was senior vice president of oncology and immunology global commercialization.
Scope Dual-Blast leads bad breath crusade
Appearing at food festivals nationwide this summer, Scope has rolled out its latest collection of products with its new Dual-Blast technology, which is designed to eliminate strong food odors like onion and garlic while killing bad breath germs.
Homeopathic items belong in pharmacy mix
In recent years homeopathic products have entered many drug store categories, including cold and allergy, baby care, pain relief, feminine care, and ear care.
Retailers can expect great things from home diagnostics category
The at-home diagnostics category is exploding. The category generated more than $190 million in sales in food, drug and mass outlets (excluding Walmart) during the 52 weeks ended May 15, according to SymphonyIRI Group Inc. data.
Cardinal tool kit warns seniors of Rx misuse
The Cardinal Health Foundation and the Ohio State University College of Pharmacy are releasing a new, interactive tool kit designed to educate senior citizens about how to avoid misuse of prescription drugs.
No injunctive relief in Express Scripts-Walgreens suit
An arbitrator has denied injunctive relief to Walgreen Co. and Express Scripts Inc. in the pharmacy benefit manager’s lawsuit against the drug chain. Walgreens issued a statement Wednesday announcing the arbitrator’s ruling, which it said was made Sunday evening.
New coalition emerges to oppose PBM merger
A new coalition of consumers, businesses and community pharmacists nationwide has formed to speak out against the proposed merger of pharmacy benefit managers Express Scripts Inc. and Medco Health Solutions Inc.